A Systematic Review of Reported Ejaculatory Dysfunction in Clinical Trials Evaluating Minimally Invasive Treatment Modalities for BPH
PURPOSE OF REVIEW: To explore the sexual outcomes following the novel minimally invasive surgical procedures for benign prostatic hyperplasia- (BPH-) related lower urinary tract symptoms (LUTS), with an emphasis on ejaculatory dysfunction (EjD).
RECENT FINDINGS: A database search with a 10-year time restriction was carried out until February 20, 2020 using MEDLINE through the PubMed Platform evaluating minimally invasive treatment modalities for BPH and their effect on EjD. After the article selection, we retrieved data for men randomized in 19 different studies with results in 40 separate published articles investigating minimally invasive BPH surgery and reporting EjD rates. To date, water vapor thermal therapy or Rezūm, prostatic urethral lift (PUL) or UroLift®, prostate artery embolization (PAE), and Aquablation showed acceptable rates (< 2%) of retrograde ejaculation by 1 year and had very low adverse events related to the procedure. Both PUL and Rezūm demonstrated lower rates when compared with PAE and Aquablation. With comparable sexual side effect profiles postoperatively, clinicians may determine which therapeutic modality is optimal for patients based on efficacy and cost-benefit. Further randomized clinical trials are required to directly compare the effect of novel minimally invasive surgical procedures for BPH-related LUTS on ejaculation and sexual function.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
---|---|
Enthalten in: |
Current urology reports - 21(2020), 12 vom: 26. Okt., Seite 54 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lokeshwar, Soum D [VerfasserIn] |
---|
Links: |
---|
Themen: |
Aquablation |
---|
Anmerkungen: |
Date Completed 03.03.2021 Date Revised 03.03.2021 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s11934-020-01012-y |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM316737283 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM316737283 | ||
003 | DE-627 | ||
005 | 20231225161728.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s11934-020-01012-y |2 doi | |
028 | 5 | 2 | |a pubmed24n1055.xml |
035 | |a (DE-627)NLM316737283 | ||
035 | |a (NLM)33104947 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lokeshwar, Soum D |e verfasserin |4 aut | |
245 | 1 | 2 | |a A Systematic Review of Reported Ejaculatory Dysfunction in Clinical Trials Evaluating Minimally Invasive Treatment Modalities for BPH |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.03.2021 | ||
500 | |a Date Revised 03.03.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a PURPOSE OF REVIEW: To explore the sexual outcomes following the novel minimally invasive surgical procedures for benign prostatic hyperplasia- (BPH-) related lower urinary tract symptoms (LUTS), with an emphasis on ejaculatory dysfunction (EjD) | ||
520 | |a RECENT FINDINGS: A database search with a 10-year time restriction was carried out until February 20, 2020 using MEDLINE through the PubMed Platform evaluating minimally invasive treatment modalities for BPH and their effect on EjD. After the article selection, we retrieved data for men randomized in 19 different studies with results in 40 separate published articles investigating minimally invasive BPH surgery and reporting EjD rates. To date, water vapor thermal therapy or Rezūm, prostatic urethral lift (PUL) or UroLift®, prostate artery embolization (PAE), and Aquablation showed acceptable rates (< 2%) of retrograde ejaculation by 1 year and had very low adverse events related to the procedure. Both PUL and Rezūm demonstrated lower rates when compared with PAE and Aquablation. With comparable sexual side effect profiles postoperatively, clinicians may determine which therapeutic modality is optimal for patients based on efficacy and cost-benefit. Further randomized clinical trials are required to directly compare the effect of novel minimally invasive surgical procedures for BPH-related LUTS on ejaculation and sexual function | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Systematic Review | |
650 | 4 | |a Aquablation | |
650 | 4 | |a Benign prostatic hyperplasia | |
650 | 4 | |a Ejaculatory dysfunction | |
650 | 4 | |a Prostate artery embolization | |
650 | 4 | |a Prostatic urethral lift | |
650 | 4 | |a Water vapor thermal therapy | |
700 | 1 | |a Valancy, David |e verfasserin |4 aut | |
700 | 1 | |a Lima, Thiago Fernandes Negris |e verfasserin |4 aut | |
700 | 1 | |a Blachman-Braun, Ruben |e verfasserin |4 aut | |
700 | 1 | |a Ramasamy, Ranjith |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current urology reports |d 2000 |g 21(2020), 12 vom: 26. Okt., Seite 54 |w (DE-627)NLM119564807 |x 1534-6285 |7 nnns |
773 | 1 | 8 | |g volume:21 |g year:2020 |g number:12 |g day:26 |g month:10 |g pages:54 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11934-020-01012-y |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 21 |j 2020 |e 12 |b 26 |c 10 |h 54 |